We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Surgical Implantation, Dosage Issues Raise FDA Flags Over Titan’s Anti-Opioid Drug
Surgical Implantation, Dosage Issues Raise FDA Flags Over Titan’s Anti-Opioid Drug
March 19, 2013
FDA reviewers appear satisfied with Titan Pharmaceuticals’ Probuphine’s overall safety, but worry surgically implanting the anti-opioid drug may cause adverse events similar to those that plagued Wyeth’s discontinued contraceptive Norplant.